fluorodeoxyglucose f18 has been researched along with Pelvic Pain in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agarwal, M; Arora, A; Parasar, DS; Purandare, NC; Rangarajan, V; Shah, S; Sharma, AR | 1 |
Camatte, S; Jeffry, L; Kerrou, K; Lecuru, F; Lelièvre, L; Metzger, U; Talbot, JN | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and Pelvic Pain
Article | Year |
---|---|
Integrated PET/CT in evaluating sarcomatous transformation in osteochondromas.
Topics: Adolescent; Adult; Cell Transformation, Neoplastic; Exostoses; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Osteochondroma; Pelvic Pain; Positron-Emission Tomography; Sarcoma; Tomography, X-Ray Computed | 2009 |
Endometriosis with FDG uptake on PET.
Topics: Abdominal Pain; Adult; CA-125 Antigen; Endometriosis; Endosonography; Female; Fluorodeoxyglucose F18; Gonadotropin-Releasing Hormone; Gynecologic Surgical Procedures; Hormones; Humans; Laparoscopy; Magnetic Resonance Imaging; Pelvic Pain; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Reoperation; Tomography, X-Ray Computed; Treatment Outcome | 2004 |